Article
The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo.
International journal of molecular sciences - 23 Jun 2021
Cresto Noémie, Gardier Camille, Gaillard Marie-Claude, Gubinelli Francesco, Roost Pauline, Molina Daniela, Josephine Charlène, Dufour Noëlle, Auregan Gwenaëlle, Guillermier Martine, Bernier Suéva, Jan Caroline, Gipchtein Pauline, Hantraye Philippe, Chartier-Harlin Marie-Christine, Bonvento Gilles, Van Camp Nadja, Taymans Jean-Marc, Cambon Karine, Liot Géraldine, Bemelmans Alexis-Pierre, Brouillet Emmanuel
Abstract excerpt
Alpha-synuclein (α-syn) and leucine-rich repeat kinase 2 (LRRK2) play crucial roles in Parkinson's disease (PD). They may functionally interact to induce the degeneration of dopaminergic (DA) neurons via mechanisms that are not yet fully understood. We previously showed that the C-terminal portion of LRRK2 (ΔLRRK2) with the G2019S mutation (ΔLRRK2G2019S) was sufficient to induce neurodegeneration of DA neurons in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
